Investcorp, a global alternative investment firm, led a $17m funding round in V-Ensure Pharma Technologies, a developer of specialty pharmaceutical formulations focused on complex generics for regulated markets, with participation from Tanas Capital. "We are delighted to partner with Investcorp as we expand our business from a CRO to a fully integrated specialty pharmaceutical company. We will continue to deliver patient centric solutions through our proprietary technology and competence in developing complex generics for regulated markets. With the backing of Investcorp’s experienced team and global network, we believe that we will be well positioned to significantly accelerate our growth. I look forward to a successful partnership with Investcorp," Satyanarayana Vemula, V-Ensure CEO.